Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06107400
What this trial is testing

Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease

Who this might be right for
Alpha Thalassemia Hemoglobin H Constant SpringHemoglobinopathiesHereditary Diseases
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army 5
Post-approval studies (Phase 4)Study completedNCT00733811
What this trial is testing

Efficacy Study of the Use of Sequential DFP-DFO Versus DFP

Who this might be right for
Beta-ThalassemiaThalassemia Major
Azienda Ospedaliera V. Cervello 213
Early research (Phase 1)UnknownNCT05777733
What this trial is testing

NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major

Who this might be right for
Thalassemia Major
Assiut University 100
Post-approval studies (Phase 4)Study completedNCT03682211
What this trial is testing

Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children

Who this might be right for
PainSickle Cell Disease
University College Dublin 31
Large-scale testing (Phase 3)Study completedNCT02604433
What this trial is testing

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia

Who this might be right for
Erythrocyte TransfusionBeta-Thalassemia
Celgene 336
Post-approval studies (Phase 4)WithdrawnNCT05228821
What this trial is testing

Voxelotor Brain Oxygenation and Neurocognitive Study

Who this might be right for
Sickle Cell Disease
Pfizer
Not applicableNot Yet RecruitingNCT07660224
What this trial is testing

The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia

Who this might be right for
Beta-Thalassemia MajorTransfusion-Dependent Thalassemia
Oman Ministry of Health 45
Not applicableStudy completedNCT07099196
What this trial is testing

Impact of Virtual Reality on Pain and Anxiety During Intravenous Cannulation Procedures Among Thalassemia Patients in UAE.

Who this might be right for
Thalassemia, BetaThalassemiaPain+2 more
Mohammed Bin Rashid University of Medicine and Health Sciences 115
Early research (Phase 1)Study completedNCT02712346
What this trial is testing

The Role of Endothelin-1 in Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
Augusta University 26
Not applicableUnknownNCT03903289
What this trial is testing

The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center

Who this might be right for
Sickle Cell Disease
Ain Shams University 20
Not applicableStudy completedNCT00804362
What this trial is testing

Validation of the Sickle Cell Disease Pain Burden Interview

Who this might be right for
Sickle Cell DiseasePain
Connecticut Children's Medical Center 131
Testing effectiveness (Phase 2)Study completedNCT01960413
What this trial is testing

Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia

Who this might be right for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0)
Vanderbilt University Medical Center 46
Not applicableStudy completedNCT02580565
What this trial is testing

Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease

Who this might be right for
Sickle Cell Disease
Nantes University Hospital 1,004
Testing effectiveness (Phase 2)Study completedNCT00004381
What this trial is testing

Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

Who this might be right for
Glucosephosphate Dehydrogenase DeficiencyHyperbilirubinemiaHemolytic Disease of Newborn
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not applicableStudy completedNCT00005277
What this trial is testing

Cooperative Study of The Clinical Course of Sickle Cell Disease

Who this might be right for
Anemia, Sickle CellBlood Disease
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT05577312
What this trial is testing

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

Who this might be right for
Beta-Thalassemia
Bioray Laboratories 39
Not applicableStudy completedNCT03609814
What this trial is testing

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

Who this might be right for
Hematologic MalignanciesNonmalignant DiseasesImmunodeficiencies+5 more
University of California, San Francisco 30
Not applicableStudy completedNCT04122378
What this trial is testing

Acupuncture for Pain in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Deepika Darbari 29
Testing effectiveness (Phase 2)Study completedNCT05405114
What this trial is testing

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Novo Nordisk A/S 96
Not applicableLooking for participantsNCT07090668
What this trial is testing

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Emory University 20
Next Page